Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisdexamfetamine (Vyas) for treatment of premature ejaculation
IRCT20160523028008N10Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lisdexamfetamine in premature ejaculation (PE), sponsored by Hamadan University of Medical Sciences. Started Mar 2021; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on IRCT20160523028008N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160523028008N10.